åžå Žæ°
æå·è³ç£
ãªãŒããŒããŒã
ããã·ã¥ããŒã
åžå Žæ°
ã€ã³ãžã±ãŒã¿ãŒ
ããªããã£ã
ååŒæ
äžå€®éæš©åååŒæ
忣åååŒæ
ãããã¯ã
ãããã¯ã
ãã£ã³ããŒã³
ã«ã¬ã³ããŒ
AstraZeneca PLCAZN#56
#56
ï¿¥25,731.09Â Â
AstraZeneca PLC Info
- æäŸ¡ç·é¡
- ï¿¥39.89T
0.25% - äžæ¥ããªã¥ãŒã
- ï¿¥21.83B
- æ ªäŸ¡åçç
- 113.45
- é åœå©åã
- 1.41%
- EPS
- ï¿¥227.05
- 52é±ã¬ã³ãž
- ï¿¥11.57Kï¿¥33.77K
ãŠã§ããµã€ã
è³ç£ã¿ã€ã
æ ªåŒ
åŸæ¥å¡
94300
èšç«
Apr 6, 1999
äž»èŠååŒæ
Nasdaq
CIKçªå·
0000901832
ããŒã¯ã³åæ ªåŒããŒã¿
- å¹³åããŒã¯ã³åäŸ¡æ Œ
- ï¿¥19.7K
- äŸ¡æ Œå·®
- +ï¿¥6.02K(-23.41%)
- ããŒã¯ã³åè³ç£æäŸ¡ç·é¡
- ï¿¥24.4M
2.38% - ããŒã¯ã³ååºæ¥é«ïŒ24æéïŒ
- ï¿¥42.74M
17.9%
AZNããUSDãžã®äº€æ
AZN
JPY
äŸ¡æ Œããã©ãŒãã³ã¹
å®
ï¿¥25.48K
ï¿¥25.48K
é«
ï¿¥26.13K
ï¿¥26.13K
èªã¿èŸŒã¿äž...
ãåŸ ã¡ãã ããããã£ãŒãããŒã¿ãèªã¿èŸŒãã§ããŸã
AstraZeneca PLC Community
Â
Â
Â
Â
Â
Â
AstraZeneca PLCã«ã€ããŠ
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
人æ°ã®ãªã¢ã«ã¯ãŒã«ãã¢ã»ãã
AstraZeneca PLC äŸ¡æ Œã®çé ä¿¡ããŒã¿
AstraZeneca PLCã®çŸåšã®åžå ŽäŸ¡æ Œã¯ï¿¥25,731.09ã24æéã®ååŒé«ã¯ï¿¥21.83Bã§ãããã®è³ç£ã®æäŸ¡ç·é¡ã¯ãéå»24æéã§-0.26%å€åããï¿¥39.89Tãšãªã£ãŠããŸãã
ããŒã¯ã³åãããAstraZeneca PLCã¯ï¿¥19,706.59ã§ååŒãããŠãããããŒã¯ã³åãããæäŸ¡ç·é¡ã¯ï¿¥24.4Mã24æéã®ååŒé«ã¯ï¿¥42.74Mã§ãããã®ããŒã¯ã³åãããè³ç£ã¯ãéå»24æéã§2.38%å€åããŸããã